Maxim Group Forecasts Strong Price Appreciation for Nutex Health (NASDAQ:NUTX) Stock

Nutex Health (NASDAQ:NUTX) had its price target raised by Maxim Group from $45.00 to $50.00 in a research note published on Tuesday, Marketbeat reports. Maxim Group currently has a buy rating on the stock.

Separately, Benchmark increased their price target on shares of Nutex Health from $30.00 to $45.00 and gave the company a “buy” rating in a research note on Wednesday, August 21st.

Nutex Health Price Performance

Shares of NASDAQ:NUTX traded down $2.30 during midday trading on Tuesday, hitting $29.03. The company’s stock had a trading volume of 14,616 shares, compared to its average volume of 42,590. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.55 and a current ratio of 1.77. The business’s 50 day simple moving average is $23.19 and its 200 day simple moving average is $13.95. Nutex Health has a 12-month low of $4.16 and a 12-month high of $39.48. The company has a market cap of $157.92 million, a P/E ratio of -3.09 and a beta of 0.11.

Insider Transactions at Nutex Health

In other news, CFO Jon Christian Bates acquired 1,350 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were bought at an average cost of $21.46 per share, with a total value of $28,971.00. Following the transaction, the chief financial officer now owns 2,277 shares in the company, valued at approximately $48,864.42. This trade represents a 145.63 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 38.52% of the company’s stock.

Institutional Trading of Nutex Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NUTX. Thompson Davis & CO. Inc. acquired a new position in Nutex Health in the third quarter valued at $494,000. International Assets Investment Management LLC acquired a new stake in shares of Nutex Health in the 3rd quarter valued at about $188,000. Finally, Essex Investment Management Co. LLC purchased a new position in Nutex Health during the 3rd quarter worth approximately $1,579,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.